Results for gonorrhoea translation from English to Maltese

gonorrhoea
gonorrea

- uncomplicated gonorrhoea: urethritis and cervicitis
urethritis u cervicitis

get tested for other sexually transmitted infections such as syphilis and gonorrhoea.
għandek tiġi ttestjat għal infezzjonijiet oħra trasmessi sesswalment bħal sifilide u gonorrea.

clinical picture compatible with gonorrhoea, e.g. urethritis, cervicitis, or salpingitis.
stampa klinika kompatibbli mal-gonorrhoea, e.g. urethritis, cervicitis, jew salpingitis

these include chlamydia, genital herpes, genital warts, gonorrhoea, hepatitis b, syphilis.
dawn jinkludu klamidja, erpete ġenitali, felul ġenitali, gonorrea, epatite b, sifilide.

significant difference was identified with regard to the indication “ uncomplicated gonorrhoea: urethritis and cervicitis”.
urethritis u cervicitis ”.

cmd(h) referral agreed on all therapeutic indications, except uncomplicated gonorrhoea: urethritis and cervicitis.
ir- riferiment tas- cmd( h) qabel fuq l- indikazzjonijiet terapewtiċi kollha ħlief dawk għal infezzjonijiet tal- gonorrea mingħajr kumplikazzjonijiet: fl- uretra u fl- għonq ta ’ l- utru. l- iskop tar- riferiment kien li jindirizza s- sigurtà u l- effikaċja ta ’ cefuroxime axetil fl - infezzjonijiet tal- gonorrea (fl- uretra u fl- għonq ta ’ l- utru) mingħajr kumplikazzjonijiet u li jikkonkludi dwar il- bilanċ bejn ir- riskju u l- benefiċċji għal din l- indikazzjoni mfittxa. is- sommarju tal- karatteristiċi tal- prodott, it- tikketta u l- fuljett ta ’ tagħrif proposti mill - applikant ġew valutati skond id- dokumentazzjoni sottomessa u skond id- diskussjoni xjentifika fil- kumitat,

the applicant had to address the safety and efficacy of cefuroximaxetil in uncomplicated gonorrhoea and to conclude on the risk-benefit balance for this sought indication.
l- applikant kellu jindirizza s- sigurtà u l- effikaċja ta ’ cefuroxim axetil għall- gonorrea mingħajr kumplikazzjonijiet u jwassal il- konklużjonijiet tiegħu dwar il- bilanċ bejn il- benefiċċju u r - riskju għal din l- indikazzjoni mfittxa.

to address the concerns of the chmp, the applicant submitted an extensive review of the literature supporting the efficacy of cefuroxime axetil in the treatment of uncomplicated gonorrhoea and specifically in cervicitis and urethritis.
biex jindirizza t- tħassib tas- chmp, l- applikant issottometta analiżi estensiva tal- litteratura li tappoġġja l- effikaċja ta ’ cefuroxime axetil għat- trattament ta ’ infezzjonijiet tal- gonorrea mingħajr kumpikazzjonijiet u speċifikament fl- għonq ta ’ l- utru u fl- uretra.

this refers to the safety and efficacy of cefuroximaxetil in uncomplicated gonorrhoea and risk- benefit balance for this sought indication and this was considered to be a serious public health concern.
dan jirreferi għas- sigurtà u l- effikaċja taċ- cefuroximaxetil f’ gonorrea ħafifa u bilanċ tar- riskju u l- benefiċċju għal din l- indikazzjoni imfittxija u dan kien ikkonsidrat bħala konċern serju għas- saħħa pubblika.

taking into account the originator spcs of cefuroxime axetil and recommendations from the literature on the use of cefuroxime in the treatment of uncomplicated gonorrhoea, it was argued that the inclusion of this indication is fully justified from a clinical and pharmacological point of view.
meta wieħed jikkunsidra l- spcs oriġinali ta ’ cefuroxime axetil u r- rakkomandazzjonijiet mil - litteratura dwar l- użu ta ’ cefuroxime fit- trattament ta ’ gonorrea mingħajr kumplikazzjonijiet, tqajjem l- argument li mill- aspett kliniku u farmakoloġiku, l- inklużjoni ta ’ din l- indikazzjoni hija ġġustifikata għal kollox.

the scope of the referral was to address the safety and efficacy of cefuroxime axetil in uncomplicated gonorrhoea (cervicitis and urethritis) and to conclude on the risk-benefit balance for this sought indication the summary of products characteristic, labelling and package leaflet proposed by the applicant has been assessed based on the documentation submitted and the scientific discussion within the committee. the chmp has recommended by consensus that the indication pertaining uncomplicated gonorrhoea (cervicitis and urethritis) should not be included in the product information.
is- chmp irrakkomanda b’ konsensus li l- indikazzjoni relatata ma ’ l- infezzjonijiet tal- gonorrea (fl- uretra u fl- għonq ta ’ l- utru) mingħajr kumplikazzjonijiet m’ għandhiex tkun inkluża fit - tagħrif dwar il- prodott.